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Abstract
Background: Living with diabetes and managing it can have substantial emotional burden on individuals. These changes might
affect individuals’ lives in terms of stress and depression. The purpose of this study was to determine the prevalence of stress and
depression among diabetic women who referred to endocrine clinic of Qazvin in 2014.
Methods: For this purpose, 250 patients (125 individuals suffering from diabetes and 125 individuals as a control group) partici-
pated in this study. All individuals completed the beck depression inventory and the cattell anxiety inventory. In addition to these,
demographic and clinical records were collected from their medical records and were analyzed by appropriate statistical methods.
Results: In terms of the Maximum of mild anxiety there were 52 diabetic individuals (41.6%) versus 69 individuals of the control
group (55.2%); in terms of Moderate-severe anxiety there were 73 cases (58.4%) versus 56 patients (44.8%) (P value = 0.031). In studying
the Maximum of mild depression, there were 43 patients (34.4%) versus 92 (73.6%); in terms of Moderate-severe depression, there
were 82 patients (65.6%) versus 33 (26.4%) (P value = 0.001). On a closer examination among age, type of diabetes, duration of diabetes,
and insulin injections; only the duration of having diabetes was significantly associated with depression as one of the mental health
variables.
Conclusions: This study showed that anxiety and depression are significantly more common among diabetic patients in compari-
son to the control group in the city of Qazvin; therefore, it is necessary to develop primary care by a system based on the reaction, so
that an effective treatment for mental health would take place and, ultimately, the impact of these interventions should be studied.
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1. Background
Diabetes is a metabolic disorder. In this disease the
body’s ability to produce insulin is lost or the body be-
comes resistant to insulin, so the produced insulin cannot
perform its normal function (1, 2). According to the statis-
tics provided by the world health organization, 285 million
people suffer from diabetes worldwide and this amount
will reach 438 million per year by 2030 (3-5). Asian coun-
tries bear a large part of diabetes epidemic and among
them Iran can also be noted whose prevalence of diabetes
is about 9.5% (6). All people with diabetes need regular
monitoring of blood glucose levels; this helps them to
manage and control diabetes daily (7). Living with chronic
conditions such as diabetes, stressful life events, and per-
sonality factors may trigger the anxiety; these situations
might make it difficult to deal with serious life situations
(8). Studies show that symptoms of low blood sugar can
sometimes be confused with anxiety which leads to a lack
of response to low levels of blood sugar; therefore, study-
ing these subjects and determining the prevalence of these
factors is of great importance (9). On the other hand,
stressful life events and personality factors trigger depres-
sion, which means that diabetes makes depression harder
(10). In people with diabetes, depression is associated with
high blood sugar levels (11) and reduced levels of self-care
(12). Studies show conflicting information about the preva-
lence of depression in people with diabetes type 1 and 2 (13).
It is, therefore, essential that the effect of both factors be
considered in studies. In a meta-analysis by Anderson et al.
it has been concluded that the prevalence of depression in
both types of diabetes is twice as much as that in the in-
dividuals without diabetes (14). Depression and anxiety in
diabetic patients is common and may affect 10% to 30% of
people. Depression in people with diabetes may be associ-
ated with a number of potential and demographic factors;
of these factors age, the use of insulin, diabetes type, and
the duration of diabetes can be noted (15). Depression and
anxiety are modifiable risk factors and treatment, then,
can improve blood sugar control and health outcomes for
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diabetic patients (13). So the aim of this study was to de-
termine the prevalence of anxiety and depression in dia-
betic patients in comparison to a control group and since
depression and anxiety are significantly higher in women
than men, this research has been focused on women (16).
2. Methods
This is a descriptive-analytic study that has been con-
ducted on the division of endocrinology at Medical Uni-
versity Hospitals in Qazvin in 2013 to 2014. The Sample
size was composed of 250 patients (125 individuals suffer-
ing from diabetes and 125 individuals as a control group)
that were chosen based on the proportion of cases with
an exposure of 50%, confidence level of 95%, and power of
90%. The cases consisted of subjects aged from 20 to 60
years from all patients referring for the treatment of dia-
betes. The control group was randomly chosen from the
nearby clubs, schools, and universities. Controls were ap-
parently healthy and were free from any chronic diseases.
This study was conducted in accordance with the priorities
of Medical University of Qazvin without any moral prob-
lems and it has been approved by the university’s ethics
committee. Inclusion criteria consisted of signing an in-
formed consent form, suffering from diabetes, full aware-
ness, and the ability to respond to questions. Exclusion
criteria were psychological disorders with any medical or
psychoanalysis treatments. On the selection day, the orig-
inal descriptive data (age, sex, type of diabetes, the use of
insulin, medical history including duration and medica-
tion use) were recorded. Then, Beck depression inventory
and Cattell anxiety inventory were completed by all the
individuals. Beck Depression Inventory contains 21 multi-
ple choice questions and each option has a range of 0 to
3 scores; higher scores indicate the severity of depression.
This questionnaire has a maximum score of 63 points in
which 0 - 4 represents a potential denial, 5 - 9 indicates
lack of depression, 10 - 18 indicates a mild depression, 19 -29
indicates a moderate depression, and 30 - 63 indicates se-
vere depression. The BDI demonstrates high internal con-
sistency with a mean coefficient alpha of 0.86 reported
for psychiatric groups and 0.81 for non-psychiatric groups
(17). The validity and reliability of the Persian version of
the Beck depression inventory in the previous studies have
been approved with Cronbach’sα of 0.83 to 0.85 (18-21).
Cattell anxiety inventory is a 40 item questionnaire.
This scale does not show the scores of total anxiety, hid-
den or obvious anxiety, and the awareness or lack of aware-
ness of an individual regarding one’s self anxiety; more-
over, its value should be interpreted in light of clinical ex-
perience. In this scale, 0 - 3 score represents a calm, phleg-
matic, stable, comfortable, and non-stressed personality.
A score of 4 - 6 indicates a moderate degree of anxiety; a
score of 7 - 8 indicates a neurotic anxious person; and fi-
nally a score of 9 - 10 indicates a person who clearly needs
help either to modify his/her position or to receive consul-
tation and psychotherapy (22). The validity of its Persian
version has been determined and its reliability has been
reported from 0.75 to 0.85 (18, 19, 23). After collecting the
data, the results were analyzed using SPSS version 22. The
data were presented using frequencies and percentages for
categorical variables and for continuous variables, means
and standard deviations were used. Variables were tested
for normality distribution by Kolomogorov-Smirnov test.
To compare continuous variables, the analysis of variance
(ANOVA) was used and for comparing the categorical vari-
ables, chi-square test was used. P value < 0.05 was consid-
ered as the significant level.
3. Results
Regarding age and gender, there was no significant dif-
ference (P value < 0.05) between patients and the control
group. The average age of the participants in the age range
of 20 to 60 years was 37.9 ± 12.66. The prevalence of de-
pression and anxiety in patients with diabetes comparing
to the control group is shown in Table 1. As can be seen, the
prevalence of depression and anxiety in the patients group
is significantly higher comparing to the control group.
In terms of the Maximum of mild anxiety, there were
52 diabetic individuals (41.6%) versus 69 individuals of the
control group (55.2%); in terms of Moderate-severe anxi-
ety, there were 73 cases (58.4%) versus 56 patients (44.8%)
(P value = 0.031). In studying the Maximum of mild de-
pression, there were 43 patients (34.4%) versus 92 (73.6%);
in terms of Moderate-severe depression, there were 82 pa-
tients (65.6%) versus 33 (26.4%) (P value = 0.001, Table 1).
On a closer examination of the groups of patients (no
control group), no significant relationship was found be-
tween age, type of diabetes, insulin injections, and the du-
ration of diabetes with the anxiety levels of the patients;
the results are shown in Table 2. Unlike anxiety, there
was a significant relationship between the duration of di-
abetes and the different levels of depression; the results
are shown in Table 3. However, regarding the type of treat-
ment, there was no significant difference between insulin
injections and age.
4. Discussion
The current study has been conducted with a need to
determine the prevalence of depression and anxiety in di-
abetic patients in Qazvin. Results showed that anxiety is
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Table 1. The Frequency of Depression and Anxiety in Patients and Control Groupa
Variables Diabetic Patients Non-Diabetic Patients Total P Value
Anxiety 0.031
Maximum of mild anxiety 52 (41.6) 69 (55.2) 121 (48.4)
Moderate-severe anxiety 73 (58.4) 56 (44.8) 129 (51.6)
Depression 0.001
Maximum of mild depression 43 (34.4) 92 (73.6) 135 (54)
Moderate-severe depression 82 (65.6) 33 (26.4) 115 (46)
aValue are expressed as No. (%).
Table 2. The Relationship Between Age and Medical Records of Patients with Anxiety
Variables Without Anxiety Mild Anxiety Neurotic Anxious Sever Anxiety P Value
Age, M (SD) 43.60 (8.82) 38.25 (11.64) 36.98 (14.02) 37.55 (12.16) 0.733
Injection of Insulin, No. (%) 0.952
Using 1 (20) 13 (27.7) 13 (23.6) 5 (27.8)
Not using 4 (80) 34 (72.3) 42 (76.4) 13 (72.2)
Diabetes, No. (%) 0.724
Type 1 0 (0) 9 (19.1) 10 (18.2) 4 (22.2)
Type 2 5 (100) 38 (80.9) 45 (81.8) 14 (77.8)
The duration of having diabetes, M (SD) 6.90 (6.54) 6.12 (3.13) 5.40 (3.10) 6.66 (4.02) 0.459
Table 3. The Relationship Between Age and Medical Records of Patients with Depression
Variables Possible Denial Lack of Depression Mild Depression Moderate Depression Severe Depression P Value
Age, M (SD) 34 (11.50) 39.20 (9.95) 43.88 (15.54) 37.26 (11.37) 33.46 (12.85) 0.081
Injection of Insulin, No. (%) 0.404
Using 3 (37.5) 1 (10) 9 (36) 15 (21.7) 4 (30.8)
Not using 5 (62.5) 9 (90) 16 (64) 54 (78.3) 9 (69.2)
Diabetes, No. (%) 0.91
Type 1 2 (25) 1 (10) 9 (16) 13 (18.8) 3 (23.1)
Type 2 6 (75) 9 (90) 21 (84) 56 (81.2) 10 (76.9)
The duration of having diabetes,
M (SD)
4.25 (1.58) 4.90 (1.79) 8.56 (4.20) 5.76 (2.54) 6.07 (2.46) 0.001
significantly higher in diabetic patients comparing to the
control group. These results are consistent with previous
studies in the literature review. In a study conducted by
Baker et al. anxiety in diabetic patients was 20% higher
than healthy individuals (24).
The prevalence of anxiety in the current study was
higher than other studies; for example, in a study con-
ducted in Mexico, the prevalence of anxiety in diabetic
patients was 52.9% (25). Regarding the difference in the
prevalence of anxiety and depression, it can be stated that
anxiety and depression have epidemic progress and this
trend emerges in the shape of the society’s mental charac-
teristics (26). For this reason, in the current study a con-
trol group was used, so that the progress of comparisons
would be examined more realistically.
Determining the symptoms of diabetes and anxiety is
important for the reason that reduced levels of blood sugar
in some cases are mistaken for anxiety which can cause
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the lack of response to low sugar levels and vice versa. In
the current study, the prevalence of depression has been
significantly higher in diabetic patients comparing to the
control group. This finding is consistent with the findings
of other studies. In a study by Yu, Ruan et al. conducted on
diabetic patients, it has been shown that 28% of individu-
als suffered from depression among whom, 18% had mild
depression, 6% had moderate depression, and only 4% suf-
fered from severe depression (27). Also, in a study by Clarke
et al. depression was higher in the disordered group com-
paring to the general population (28). For considering the
cause of this issue, biological changes associated with de-
pression which increase the possibility of developing dia-
betes can be pointed out. This impact applies by the diffi-
culty in obtaining information about managing diabetes
and the follow-up diabetes management (29).
Depression and anxiety are a normal part of the adapta-
tion to lifestyle changes of people and over time, these feel-
ings can turn into permanent depression and anxiety (5).
Research shows that one-fourth of individuals who suffer
from diabetes type 2 have experienced depression in their
lives. This number is different for anxiety and it is about
one-sixth. Regarding individuals with type 1 diabetes, this
number for depression and anxiety is one-fifth and one-
seventh, respectively (9). Since diabetes type 1 and 2 are
somewhat different in terms of age, onset of disease, dura-
tion, management, and the symptoms, the current study
was to examine the relationship between these two types
of diabetes (30). Although the prevalence of depression
and anxiety was higher in patients with type 2 diabetes
comparing to type 1, this difference was not statistically sig-
nificant. Many life aspects of diabetes such as the need to
keep a diabetic diet, active lifestyle, target glucose levels,
and starting insulin injection increase the risk of depres-
sion and anxiety (5). This has led this study to consider
the relationship between the prevalence of depression and
anxiety with the injection of insulin, the type of diabetes,
and the duration of diabetes. The results showed that there
is no significant relationship between these variables and
the levels of anxiety. Unlike anxiety in the current study,
there was a significant relationship between the duration
of disease and depression. This relationship was also found
in a study by Mosaku et al. (31). The results have shown that
metabolic disorder of glucose in mild cases is associated
with depression. When the duration of disease increases,
it can cause the occurrence of symptoms and hopelessness
of improvement which can show its effect as depression.
In a study by Hermamms et al. this relationship has not
been observed regarding anxiety (32). With these factors
not being significant, it can be reasoned that people with
diabetes may consider their anxiety and depression as a
non-related result of diabetes. From these factors, constant
problems and stresses of life, serious medical conditions,
drug abuse, personality factors, and chemical changes in
the brain can be pointed out (32), so it is essential that fu-
ture studies also consider these factors.
Anxiety and depression in some people can cause more
problems for the management of diabetes. Regardless of
whether the mental health conditions occur before or af-
ter the occurrence of diabetes, untreated depression can
affect the ability of individuals to manage diabetes. Based
on the assumptions presented in the literature review on
the disorders of adrenal axis, pituitary, hypothalamus, and
excessive activity of the sympathetic nervous system due
to fears of symptoms and of mortality and the complica-
tions of physiological processes accelerates anxiety and de-
pression in the elderly (33). This hypothesis led the current
study to examine these relationships which there were
no significant differences between age and mental health
with the variables of the study. This finding was also con-
firmed by several other studies; of such studies, a study by
Collins et al. can be mentioned (34).
Since the controlled study on this subject is limited
and is mostly based on the self-report questionnaires,
there is a need for diagnosis criteria in addition to the con-
trolled study for more comprehensive results; this was one
of the limitations of the current study. One of the advan-
tages of the current study was the use of control group and
an appropriate sample size for the final comparison. This
fact improves the generalizability of the data. Early detec-
tion of risk factors associated with anxiety and depression
in people with diabetes has a special importance and these
factors have been examined in the current study as far as it
was possible.
4.1. Conclusion
This study showed that anxiety and depression in peo-
ple with diabetes are more common than in the control
group in the city of Qazvin. These factors can lead to an in-
creased risk of developing diabetes and reduced health, so
it is necessary that primary care be developed by a system
based on the reaction. Therefore, with the help of these fac-
tors, an effective treatment for mental health could take
place. Such action could be a necessary infrastructure for
the better management of diabetes and finally the impact
of such interventions should be investigated.
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